Abstract 1620: ATG-112, a novel ALPP/G x CD3 bispecific T cell engager, for the treatment of ALPP/G+ solid tumors
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Antengene Corporation Limited (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148854767
Cites:
Cited by:
Related to: